Diabetes mellitus in a new kindred with familial hypobetalipoproteinemia and an apolipoprotein B truncation (apoB-55)

Atherosclerosis

Volumn 136, Issue 2, 1998, Pages 289-295

  Pulai, J I ^a   Latour, M A ^a   Kwok, Pui Yan ^b   Schonfeld, Gustav ^a  

^a Division of Atherosclerosis   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Apolipoprotein B; Diabetes mellitus; Genetics; Truncation

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; DIABETES MELLITUS; DISORDERS OF LIPOPROTEIN METABOLISM; DNA SEQUENCE; GENE MUTATION; GENOTYPE; HUMAN; HYPOBETALIPOPROTEINEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEINS B; BASE SEQUENCE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOBETALIPOPROTEINEMIAS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0032005350     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00222-0     Document Type: Article

References (43)

1. Linton M.F., Farese Jr R.V., Young S.G. Familial hypobetalipoproteinemia. J Lipid Res. 34:1993;521-541.
2. Malloy M.J., Kane J.O., Hardman A., Hamilton R.L., Dalal K.B. Normotriglicerydemic abetalipoproteinemia: absence of the apoB-100 apolipoprotein. J Clin Invest. 67:1981;1441-1450.
3. Kane J.P. Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol. 45:1983;637-650.
4. Young S.G. Recent progress in understanding apolipoprotein-B. Circulation. 82:1990;1574-1594.
5. Young S.G., Linton M.F. Genetic abnormalities in apolipoprotein-B. Trends Cardiovasc Med. 1:1991;59-65.
6. Collins D.R., Knott T.J., Pease R.J., Powell L.M., Wallis S.C., Robertson S., Pullinger C.R., Milne R.W., Marcel Y.L., Humphries S.E., Talmud P.J., Lloyd J.K., Miller N.E., Muller D.M., Scott J. Truncated variants of apolipoprotein B cause hypobetalipoproteinemia. Nucleic Acids Res. 16:1988;8361-8375.
7. Fazio S., Sidoli A., Vivenzio A., Maietta S., Giampaoli S., Menotti A., Antonini R., Urbinati G., Baralle E., Ricci G. A form of familial hypobetalipoproteinaemia not due to a mutation in the Apolipoprotein-B Gene. J Intern Med. 229:1991;41-47.
8. Chan L. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J Biol Chem. 267:1992;25621-25624.
9. Schonfeld G. Inherited disorders of lipid transport. Endocrinol Metabol Clin North Am. 19:1990;229-257.
10. Schonfeld G. The hypobetalipoproteinemias. Annu Rev Nutr. 15:1995;23-34.
11. Schonfeld G, Krul ES, Genetic defects in lipoprotein metabolism. In: Goldbourt U, de Faire U, Berg K, editors. Genetic Factors in Coronary Heart Disease. Dordrecht: Kluwer, 1994:239-266.
12. Knott T.J., Pease R.J., Powell L.M., Wallis S.C., Rall S.C. Jr., Innerarity T.L., Blackhart B.B., Taylor W.H., Marcel Y., Milne R., Johnson D., Fuller M., Lusis A.J., McCarthy B.J., Mahley R.W. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature. 323:1981;734-738.
13. Powell L.M., Wallis S.C., Pease R.J., Edwards Y.H., Knott T.J., Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein B-48 in intestine. Cell. 50:1987;831-840.
14. Farese R.V., Linton M.F., Young S.G. Apolipoprotein-B gene mutations affecting cholesterol levels. J Intern Med. 231:1992;643-652.
15. Welty F.K., Ordovas J., Schaefer E.J., Wilson P.W., Young S.G. Identification and molecular analysis of two ApoB gene mutations causing low plasma cholesterol levels. Circulation. 92:1995;2036-2040.
16. Groenewegen W.A., Krul E.S., Averna M.R., Pulai J., Schonfeld G. Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2). Arterioscler Thromb. 14:1994;1695-1704.
17. Huang L.S., Kayden H., Sokol R.J., Breslow J.L. ApoB gene nonsense and splicing mutations in a compound heterozygote for familial hypobetalipoproteinemia. J Lipid Res. 32:1991;1341-1348.
18. Talmud P.J., Krul E.S., Pessah M., Gay G., Schonfeld G., Humphries S.E., Infante R. Donor splice mutation generates a lipid-associated apolipoprotein B-27.6 in a patient with homozygous hypobetalipoproteinemia. J Lipid Res. 5:1994;468-477.
19. Farese R.V., Garg A., Pierotti V., Vega G.L., Young S.G. A truncated species of apolipoprotein B, B83, associated with hypobetalipoproteinemia. J Lipid Res. 33:1992;569-577.
20. Aguilar-Salinas C.A., Barrett P.H.R., Parhofer K.G., Young S.G., Tessereau D., Bateman J., Quinn C., Schonfeld G. Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. Arterioscler Thromb. 15:1995;71-80.
21. Parhofer K.G., Barrett P.H.R., Bier D.M., Schonfeld G. Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate (in vivo studies in ApoB89, apoB-75, apoB54.8 and apoB-31 heterozygotes). J. Lipids Res. 37:1996;844-852.
22. Lipid Research Clinics Population Studies Data Book. The prevalence study. Bethesda, Maryland: DHHS, 1980; 80-1527.
23. Contois J.H., McNamara J.R., Lammi-Keefe C.J., Wilson P.W.F., Massov T., Schaefer E.J. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem. 42(4):1996;515-523.
24. Cole T.G., Kitchens R.T., Daugherty A., Schonfeld G. An improved method of separation of triglyceride-rich lipoproteins by FPLC. Pharmacia BioCommun. 4:1988;4-6.
25. Lee D.M., Downs D. A quick and large-scale density gradient subfraction method for low density lipoproteins. J Lipid Res. 23:1982;14-27.
26. Krul E.S., Parhofer K.G., Barrett H.R., Wagner R.D., Schonfeld G. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. J Lipid Res. 33:1992;1037-1050.
27. Krul E.S., Kinoshita M., Talmud P., Humphries S.E., Turner S., Goldberg A.C., Cook K., Boerwinkle E., Schonfeld G. Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. Arteriosclerosis. 9:1989;856-868.
28. Knott T.J., Powell L.M., Pease R.J., Lusis A.J., Wallis S.C., McCarthy B.J., Mahley R.W., Levy-Wilson B., Scott J., Blackhart B. Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res. 4(18):1986;7501-7503.
29. Saiki R.K., Gelfand D.H., Stoffel S.J., Scharf S., Higuchi R., Horn G.T., Mullis K.B., Erlich H.A. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science. 239:1988;487-491.
30. Sanger F., Coulson A.R., Nicklen S. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 74:1977;5463-5467.
31. Kwok P.Y., Carlson C., Yager T.D., Ankener W., Nickerson D.A. Comparative analysis of human DNA variations by fluorescence-based sequencing of PCR-products. Genomics. 23:1994;138-144.
32. Maniatis T, Fritsch ER, Sambrook J. Molecular Cloning: A Laboratory Mannual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1982.
33. Boerwinkle E., Fourest E., Chan I., Xiong W. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction applications to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci USA. 86:1989;212-216.
34. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein-E by gene amplification and cleavage with HhaI. J Lipid Res. 31:1990;545-548.
35. Groenewegen W.A., Krul E.S., Schonfeld G. Apolipoprotein B-52 mutation associated with hypobetalipoproteinemia is compatible with a misaligned pairing deletion mechanism. J Lipid Res. 34:1993;971-981.
36. Wagner R.D., Krul E.S., Tang J.J., Parhofer K.G., Garlock K., Talmud P., Schonfeld G. ApoB-54.8, a truncated apolipoprotein found primarily in VLDL, is associated with a nonsense mutation in the ApoB gene and hypobetalipoproteinemia. J Lipid Res. 32:1991;1001-1011.
37. Steiner G. Atherosclerosis, The major complication of diabetes. In: Vranic M, Hollenberg C, Steiner G, editors. Comparison of Type I and Type II Diabetes: Similarities and Dissimilarities in Ethiology, Pathogenesis and Complications. New York: Plenum, 1985, 277-297.
38. Stern M.P., Haffner S.M. Dyslipidemia in Type II diabetes. Diabetes Care. 14:1991;1144-1159.
39. Groenewegen W.A., Averna M.R., Pulai J., Krul E.S., Schonfeld G. Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL. J Lipid Res. 35:1994;1012-1025.
40. Mordasini R., Schlierf G., Huber I., Oster P., Riva G. Familial hypobetalipoproteinaemia and diabetes mellitus. Dtsch Med Wochenschr. 102:1977;1549-1552.
41. Talmud P.J., Converse C., Krul E.S., Huq L., Mcilwaine G.G., Series J.J., Boyd P., Schonfeld G., Dunning A., Humphries S. A novel truncated apolipoprotein B (apo B55) in a patient with familial hypobetalipoproteinemia and atypical retinitis pigmentosa. Clin Genet. 42:1992;62-70.
42. Caloundre C., Miller J.H., Farabaugh P.J., Gilbert W. Molecular basis of base substitution hotspots in Eschericia coli. Nature. 274:1978;775-780.
43. Cooper D.N., Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet. 85:1990;55-74.